FR2168924A2 - Hetacephalexin compsns - for human and veterinary antibacterial therapy, and as foodstuff additive - Google Patents
Hetacephalexin compsns - for human and veterinary antibacterial therapy, and as foodstuff additiveInfo
- Publication number
- FR2168924A2 FR2168924A2 FR7202591A FR7202591A FR2168924A2 FR 2168924 A2 FR2168924 A2 FR 2168924A2 FR 7202591 A FR7202591 A FR 7202591A FR 7202591 A FR7202591 A FR 7202591A FR 2168924 A2 FR2168924 A2 FR 2168924A2
- Authority
- FR
- France
- Prior art keywords
- hetacephalexin
- compsns
- human
- foodstuff additive
- antibacterial therapy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/14—Compounds having a nitrogen atom directly attached in position 7
- C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
- C07D501/58—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3 with a nitrogen atom, which is a member of a hetero ring, attached in position 7
Abstract
Therapeutic compsns. contng. as active component hetacephalexin or one of its pharmaceutically acceptable salts, esp. the sodium salt of D-hetacephalexin. In mice, its CD50 against Sf. pyogenes A 9604, is 2 x 36 mg./kg. orally and 2 x 24 mg./kg. s.c. Against E. coli the CD50 is 2 x 26 mg./kg. both orally and s.c.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR7202591A FR2168924A2 (en) | 1972-01-26 | 1972-01-26 | Hetacephalexin compsns - for human and veterinary antibacterial therapy, and as foodstuff additive |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR7202591A FR2168924A2 (en) | 1972-01-26 | 1972-01-26 | Hetacephalexin compsns - for human and veterinary antibacterial therapy, and as foodstuff additive |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2168924A2 true FR2168924A2 (en) | 1973-09-07 |
FR2168924B2 FR2168924B2 (en) | 1975-10-10 |
Family
ID=9092486
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR7202591A Granted FR2168924A2 (en) | 1972-01-26 | 1972-01-26 | Hetacephalexin compsns - for human and veterinary antibacterial therapy, and as foodstuff additive |
Country Status (1)
Country | Link |
---|---|
FR (1) | FR2168924A2 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2907153A1 (en) * | 1978-02-23 | 1979-08-30 | Shionogi & Co | 7 BETA - (5-OXO-4-PHENYLIMIDAZOLIDIN- 1-YL) -3-CHLORINE-3-CEPHEM-4-CARBONIC ACID DERIVATIVES AND METHOD FOR THEIR PRODUCTION |
-
1972
- 1972-01-26 FR FR7202591A patent/FR2168924A2/en active Granted
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2907153A1 (en) * | 1978-02-23 | 1979-08-30 | Shionogi & Co | 7 BETA - (5-OXO-4-PHENYLIMIDAZOLIDIN- 1-YL) -3-CHLORINE-3-CEPHEM-4-CARBONIC ACID DERIVATIVES AND METHOD FOR THEIR PRODUCTION |
Also Published As
Publication number | Publication date |
---|---|
FR2168924B2 (en) | 1975-10-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY818A (en) | Treatment of water of aqueous systems | |
AU5678773A (en) | Treatment of teeth | |
CA986292A (en) | Treatment of water or aqueous systems | |
CA925654A (en) | Invalid bed construction | |
FR2168924A2 (en) | Hetacephalexin compsns - for human and veterinary antibacterial therapy, and as foodstuff additive | |
EG10753A (en) | Pyrimidine derivatives active as antibacterials used for human hygiene | |
CA982493A (en) | Treatment of brine | |
PH10188A (en) | 6-(l-3-acylamidoacetamido)-penicillanic acids,their pharmaceutically acceptable salts and their medicinal uses | |
CA943128A (en) | Penicillins, their preparation and their pharmaceutical use | |
AU454611B2 (en) | Thienyl-fattyacid derivatives processes for their production, and their use as therapeutic agents | |
ZA734647B (en) | A preventive and/or curative treatment of certain intestinal infections | |
AU452550B2 (en) | The use of diphenylsulfones inthe treatment of mareks disease | |
CA936653A (en) | Treatment of titanium dioxide | |
IL36487A0 (en) | Derivatives of phenyl-azolyl-fatty acids,their production and their use as medicines | |
AU462304B2 (en) | treatment OF BRINES BY CHLORINATION | |
AU477100B2 (en) | Aqueous crystallization of zylitol | |
CA1019740A (en) | "amino propanediol" derivatives, preparation process and therapeutic applications to humans | |
AU5227273A (en) | Treatment of respiration conditions using hydroxycyclohexylamino compounds | |
FR2099449A1 (en) | Tetracycline 3,4,5-trimethoxybenzoate trihydrate - a stable tasteless salt of tetracycline with similar activity | |
FR2035781A1 (en) | Glucosamine-based medicaments | |
FR2036801A1 (en) | Coccidiostatic preparation containing antibiotic x-537a or a salt ther - eof | |
AU497649B2 (en) | Treatment of heliencephalitis, thermoplegia and combat troubles in domestic animals and poultry | |
CA971965A (en) | Dibenzoxepin therapeutic agent | |
GB1036059A (en) | Improvements in or relating to the inhibition of bacterial growth | |
CA1013611A (en) | Prevention of pecting related diseases in ruminants |